Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
J Thorac Cardiovasc Surg ; 167(5): 1733-1744, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-36775783

RESUMO

OBJECTIVE: Intervention for repair of secondary mitral valve disease is frequently associated with recurrent regurgitation. We sought to determine if there was sufficient evidence to support inclusion of anatomic indices of leaflet dysfunction in the management of secondary mitral valve disease. METHODS: We performed a systematic review and meta-analysis of published reports comparing anatomic indices of leaflet dysfunction with the complexity of valve repair and the outcome from intervention. Patients were stratified by the severity of leaflet dysfunction. A secondary analysis was performed comparing outcomes when procedural complexity was optimally matched to severity of leaflet dysfunction and when intervention was not matched to dysfunction. RESULTS: We identified 6864 publications, of which 65 met inclusion criteria. An association between the severity of leaflet dysfunction and the procedural complexity was highly predictive of satisfactory freedom from recurrent regurgitation. Patients were categorized into 4 groups based on stratification of leaflet dysfunction. Satisfactory results were achieved in 93.7% of patients in whom repair complexity was appropriately matched to severity of leaflet dysfunction and in 68.8% in whom repair was not matched to dysfunction (odds ratio, 0.148; 95% confidence interval, 0.119-0.184; P < .0001). CONCLUSIONS: For patients with secondary mitral valve disease, satisfactory outcome from valve repair improves when procedural complexity is matched to anatomic indices of leaflet dysfunction. Anatomic indices of leaflet dysfunction should be considered when planning interventions for secondary mitral regurgitation. Routine inclusion of anatomic indices in trial design and reporting should facilitate comparison of results and strengthen guidelines. There are sufficient data to support anatomic staging of secondary mitral valve disease.


Assuntos
Insuficiência da Valva Mitral , Prolapso da Valva Mitral , Humanos , Valva Mitral/diagnóstico por imagem , Valva Mitral/cirurgia , Insuficiência da Valva Mitral/diagnóstico por imagem , Insuficiência da Valva Mitral/etiologia , Insuficiência da Valva Mitral/cirurgia , Fatores de Tempo , Resultado do Tratamento
2.
J Cardiothorac Vasc Anesth ; 38(3): 616-625, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38087669

RESUMO

The Intersocietal Accreditation Commission (IAC) is a nonprofit accrediting organization committed to ensuring the quality of diagnostic imaging and related procedures. It comprises a collaboration of stakeholders spanning numerous medical professionals and specialties. In a recent initiative, IAC Echocardiography introduced a new accreditation specifically for Perioperative Transesophageal Echocardiography (PTE). This accreditation process is anchored in rigorous clinical peer review to ensure diagnostic quality and report accuracy, thus maintaining high standards of medical care. The authors present the inaugural 4 sites to achieve IAC accreditation for PTE, which have collaborated to share their experiences in achieving this accreditation. This review endeavors to offer actionable insights and proven solutions to navigate the accreditation journey for others. Mirroring the IAC Standards and Guidelines for PTE accreditation, this review is divided into three pivotal sections as follows: (1) organization of a perioperative echocardiography service, including stakeholder engagement to facilitate the application for accreditation; (2) performance of examinations and reporting; and (3) instituting quality improvement strategies and establishing a robust program. The pursuit of accreditation in PTE is to transcend a mere compliance exercise. It signifies a dedication to excellence, continual growth, and, above all, to the well-being of patients.


Assuntos
Acreditação , Ecocardiografia Transesofagiana , Humanos , Ecocardiografia , Melhoria de Qualidade
4.
CASE (Phila) ; 5(3): 137, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34195511
5.
CASE (Phila) ; 5(2): 89, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33912774
7.
CASE (Phila) ; 4(6): 473, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33376836
8.
CASE (Phila) ; 4(5): 315, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33103014
10.
CASE (Phila) ; 4(4): 199, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32835158
11.
CASE (Phila) ; 4(2): 53, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32685794
12.
13.
J Am Soc Echocardiogr ; 33(6): 692-734, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32503709

RESUMO

Intraoperative transesophageal echocardiography is a standard diagnostic and monitoring tool employed in the management of patients undergoing an entire spectrum of cardiac surgical procedures, ranging from "routine" surgical coronary revascularization to complex valve repair, combined procedures, and organ transplantation. Utilizing a protocol as a starting point for imaging in all procedures and all patients enables standardization of image acquisition, reduction in variability in quality of imaging and reporting, and ultimately better patient care. Clear communication of the echocardiographic findings to the surgical team, as well as understanding the impact of new findings on the surgical plan, are paramount. Equally important is the need for complete understanding of the technical steps of the surgical procedures being performed and the complications that may occur, in order to direct the postprocedure evaluation toward aspects directly related to the surgical procedure and to provide pertinent echocardiographic information. The rationale for this document is to outline a systematic approach describing how to apply the existing guidelines to questions on cardiac structure and function specific to the intraoperative environment in open, minimally invasive, or hybrid cardiac surgery procedures.


Assuntos
Ecocardiografia Transesofagiana , Cirurgiões , Anestesiologistas , Ecocardiografia , Humanos , Salas Cirúrgicas , Estados Unidos
14.
J Am Soc Echocardiogr ; 33(6): 683-689, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32503707

RESUMO

The grave clinical context of the coronavirus disease 2019 (COVID-19) pandemic must be understood. Italy is immersed in the COVID-19 pandemic. Most of the world will soon follow. The United States currently has the most documented cases of COVID-19 of any nation. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated acute cardiomyopathy is common in critical care patients and is associated with a high mortality rate. Patients with COVID-19 frequently require mechanical support for adequate oxygenation. A severe shortfall of ventilators is predicted. Of equal concern is the projected shortage of trained professionals required to care for patients on mechanical ventilation. Ultrasonography is proving to be a valuable tool for identifying the pulmonary manifestations and progression of COVID-19. Lung ultrasound also facilitates successful weaning from mechanical ventilation. Ultrasonography of the lung, pleura, and diaphragm are easily mastered by experienced echocardiographers. Echocardiography has an established role for optimal fluid management and recognition of cardiac disease, including SARS-CoV-2-associated acute cardiomyopathy. Cardiologists, anesthesiologists, sonographers, and all providers should be prepared to commit their full spectrum of skills to mitigate the consequences of the pandemic. We should also be prepared to collaborate and cross-train to expand professional services as necessary. During a declared health care crisis, providers must be familiar with the ethical principles, organizational structure, practical application, and gravity of limited resource allocation.


Assuntos
Betacoronavirus , Doenças Cardiovasculares/diagnóstico , Infecções por Coronavirus/complicações , Ecocardiografia/métodos , Pandemias , Pneumonia Viral/complicações , Alocação de Recursos/ética , COVID-19 , Doenças Cardiovasculares/complicações , Humanos , SARS-CoV-2
15.
CASE (Phila) ; 4(1): 1, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32149203
16.
CASE (Phila) ; 3(5): 187-188, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31709368
19.
CASE (Phila) ; 3(3): 89, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31286085
20.
CASE (Phila) ; 3(2): 43, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31049476
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...